Cover Image

Severe Cutaneous Adverse Reaction (SCAR): Clinical pharmacologists' viewpoint

Saved in:

Bibliographic Details
Main Authors:	Nusrat Shafiq (Author), Samiksha Bhattacharjee (Author), Samir Malhotra (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Severe Cutaneous Adverse Drug Reaction
by: Damayanti Damayanti, et al.
Published: (2017)

Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022)

A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
by: S. R. Gilyarevskiy, et al.
Published: (2019)

Recent advances in severe cutaneous adverse drug reaction
by: Sudip Das, et al.
Published: (2018)

Long-term outcome of patients with severe cutaneous adverse reactions
by: Yoko Kano, et al.
Published: (2013)

Severe cutaneous adverse drug reactions: A clinicoepidemiological study
by: Sarita Sasidharanpillai, et al.
Published: (2015)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
by: Chih-Jung Chang, et al.
Published: (2020)

PharmSuitePro - the automated workplace of clinical pharmacologist
by: V. M. Tcvetov
Published: (2020)

Severe cutaneous adverse reactions to drugs: a case series study
by: Clarisse F. CASTRO, et al.
Published: (2020)

Adverse cutaneous drug reaction
by: Nayak Surajit, et al.
Published: (2008)

Perspectives on training quantitative systems pharmacologists
by: Tongli Zhang, et al.
Published: (2022)

Beta-blockers in cardiac arrhythmias-Clinical pharmacologist's point of view
by: Łukasz Wołowiec, et al.
Published: (2023)

Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist
by: M. V. Zhuravleva, et al.
Published: (2020)

ANALGETICS-ANTIPYRETICS IN PEDIATRICIAN'S PRACTICE: THE POINT OF VIEW OF CLINICAL PHARMACOLOGIST
by: G.G. Ketova
Published: (2009)

ANALGETICS-ANTIPYRETICS IN PEDIATRICIAN'S PRACTICE: THE POINT OF VIEW OF CLINICAL PHARMACOLOGIST
by: G.G. Ketova
Published: (2009)

Clinicoepidemiological Profile of Severe Cutaneous Adverse Drug Reaction: A Retrospective Study
by: Damayanti Damayanti, et al.
Published: (2019)

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis
by: Qiancheng Deng, et al.
Published: (2017)

The role of frozen section in the rapid diagnosis of severe cutaneous adverse drug reactions
by: Rajam Nicholas, et al.
Published: (2021)

PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
by: D. A. Sychev, et al.
Published: (2015)

PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST
by: D. A. Sychev, et al.
Published: (2015)

The Contribution of Clinical Pharmacologists in Precision Medicine: An Opportunity for Health Care Improvement
by: Davide Grisafi, PhD, PharmD, et al.
Published: (2021)

Medication errors in hematology-oncology ward by consultation : the role of the clinical pharmacologist
by: Ali Eishy Oskoyi, et al.
Published: (2021)

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
by: Therdpong Tempark, et al.
Published: (2022)

Sports pharmacology: A medical pharmacologist's perspective
by: Harshad O Malve
Published: (2018)

Spectrum of severe cutaneous adverse drug reactions among pediatric population and management options
by: Sameer Abrol, et al.
Published: (2022)

Severe cutaneous adverse reactions in a tertiary care center in JamaicaCapsule Summary
by: Alicia J.S. McNish, BMedSc, MBBS, DM, et al.
Published: (2024)

Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia
by: Mohammed I. AlJasser
Published: (2023)

In Silico Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
by: Kaori Ambe, et al.
Published: (2021)

Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations
by: Javier Gil-Lianes, et al.
Published: (2024)

Cutaneous Scarring: A Clinical Review
by: Richard Baker, et al.
Published: (2009)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
by: Gabriela Rossi, et al.
Published: (2021)

Unusual and interesting adverse cutaneous drug reactions
by: Vaishali Masatkar, et al.
Published: (2018)

Controversies in the management of cutaneous adverse drug reactions
by: Yashpal Manchanda, et al.
Published: (2018)

Skin Test for Cutaneous Adverse Drug Reactions
by: Yusuf Wibisono, et al.
Published: (2020)

Adverse cutaneous reactions induced by exposure to woods
by: Dorota Chomiczewska-Skóra
Published: (2013)

Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
by: Leore Lavin, MSc, et al.
Published: (2024)

Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions
by: Pansakon Wattanachai, et al.
Published: (2023)

A Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib
by: Joseph Gabriel Gabriel MD, et al.
Published: (2017)

Clinical profile and comparison of causality assessment tools in cutaneous adverse drug reactions
by: Ranjana Beniwal, et al.
Published: (2019)

A Comprehensive Review of <i>HLA</i> and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
by: Chiraphat Kloypan, et al.
Published: (2021)